Animal testing is yesterday's gold standard. AxoSim's Nerve-on-a-Chip® delivers human data, faster to save you hundreds of millions of dollars and years of wasted patent life, while allowing you to develop more effective drugs.
Learn More
Our technology enables researchers to predict human outcomes in the lab. We deliver accurate preclinical testing to help develop safer, more effective drugs.
Almost 90% of drugs that look promising in animal models fail when tested in humans, driving up the average cost and time of new drug development to $2.6 billion and 10 years or more. We deliver predictive human data in just weeks and at a fraction of the cost of in vivo studies.
Achieve the predictive readouts critical to your R&D success. We deliver clinically-relevant functional and structural metrics to improve success rates.
AxoSim's Nerve-on-a-Chip® platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
The Mini Brain is a high quality 3D miniature brain organoid designed to serve as a human-relevant model in preclinical drug discovery.
Growing concern suggests that some chemicals exert (developmental) neurotoxicity (DNT and NT) and are linked to the increase in incidence of autism, […]
Read MoreThe use of advanced in vitro testing is a powerful tool to develop predictive cellular assays suitable for improving the high attrition […]
Read MoreHuman in vitro models of brain neurophysiology are needed to investigate molecular and cellular mechanisms associated with neurological disorders and neurotoxicity. We […]
Read MoreDevelopment of “organ-on-a-chip” systems for neuroscience applications are lagging due in part to the structural complexity of the nervous system and limited […]
Read More
